262 related articles for article (PubMed ID: 15949941)
21. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease.
Lumbreras M; Baamonde C; Martínez-Cué C; Lubec G; Cairns N; Sallés J; Dierssen M; Flórez J
Amino Acids; 2006 Nov; 31(4):449-56. PubMed ID: 16583316
[TBL] [Abstract][Full Text] [Related]
22. Glutamate-induced antigenic changes of phospholipase C-delta in cultured cortical neurons.
Shimohama S; Akaike A; Tamura Y; Matsushima H; Kume T; Fujimoto S; Takenawa T; Kimura J
J Neurosci Res; 1995 Jun; 41(3):418-26. PubMed ID: 7563235
[TBL] [Abstract][Full Text] [Related]
23. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
[TBL] [Abstract][Full Text] [Related]
24. Relevance of COX-2 gene expression in dementia with lewy bodies associated with Alzheimer pathology.
Saldaña M; Pujols L; ; Roca-Ferrer J; Cardozo A; Aguilar E; Bonastre M; Marin C
Mov Disord; 2008 Apr; 23(6):804-10. PubMed ID: 18307244
[TBL] [Abstract][Full Text] [Related]
25. Verbal and visuospatial deficits in dementia with Lewy bodies.
Johnson DK; Morris JC; Galvin JE
Neurology; 2005 Oct; 65(8):1232-8. PubMed ID: 16247050
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
Kumar U; Patel SC
Brain Res; 2007 Feb; 1131(1):187-96. PubMed ID: 17182012
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
[TBL] [Abstract][Full Text] [Related]
28. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
[TBL] [Abstract][Full Text] [Related]
29. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease.
Baig S; Kehoe PG; Love S
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):205-15. PubMed ID: 17971072
[TBL] [Abstract][Full Text] [Related]
30. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
Reinikainen KJ; Soininen H; Riekkinen PJ
J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
[TBL] [Abstract][Full Text] [Related]
31. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
Jellinger KA; Attems J
Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
[TBL] [Abstract][Full Text] [Related]
33. Behavioural and neuropsychological correlates of frontal lobe features in dementia.
Engelborghs S; Maertens K; Mariën P; Vloeberghs E; Somers N; Nagels G; De Deyn PP
Psychol Med; 2006 Aug; 36(8):1173-82. PubMed ID: 16700962
[TBL] [Abstract][Full Text] [Related]
34. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
[TBL] [Abstract][Full Text] [Related]
35. Differences and similarities in the neuropsychological profile of dementia with Lewy bodies and Alzheimer's disease in the early stage.
Guidi M; Paciaroni L; Paolini S; De Padova S; Scarpino O
J Neurol Sci; 2006 Oct; 248(1-2):120-3. PubMed ID: 16784757
[TBL] [Abstract][Full Text] [Related]
36. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease.
Stavitsky K; Brickman AM; Scarmeas N; Torgan RL; Tang MX; Albert M; Brandt J; Blacker D; Stern Y
Arch Neurol; 2006 Oct; 63(10):1450-6. PubMed ID: 17030662
[TBL] [Abstract][Full Text] [Related]
37. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
[TBL] [Abstract][Full Text] [Related]
38. Aberrant modulation of a delayed rectifier potassium channel by glutamate in Alzheimer's disease.
Poulopoulou C; Markakis I; Davaki P; Tsaltas E; Rombos A; Hatzimanolis A; Vassilopoulos D
Neurobiol Dis; 2010 Feb; 37(2):339-48. PubMed ID: 19850126
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice.
Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I
Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
Allan LM; Ballard CG; Burn DJ; Kenny RA
J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
